A previous study has shown that glioma cells expressing PTEN-Y204F, a mutation that leads to lack of PTEN nuclear localisation and functions such as dsDNA damage repair, are sensitive to radiation therapy (Ma et al., 2019). This evidence concerns the gene PTEN and central nervous system cancer.